Preventing early childhood transmission of hepatitis B in remote aboriginal communities in Northern Australia.

Abstract

BACKGROUND:

Chronic hepatitis B is a public health concern in Aboriginal communities in the Northern Territory of Australia with prevalence almost four times the non-Aboriginal population. Infection is suspected to mainly occur in early life, however, the mode of transmission and vaccine effectiveness is not known in this population. WHO has set a target for hepatitis B elimination by 2030; elimination in this disproportionately affected population in Australia will require understanding of the modes of transmission and vaccine effectiveness.

METHODS:

We conducted the study at four very remote Aboriginal communities. We approached mothers who had chronic hepatitis B and had given birth between 1988 and 2013 for consent. We obtained hepatitis B serology, immunisation and birth details from the medical record. If both mother and child had hepatitis B viral DNA detected, we performed viral whole genome sequencing.

RESULTS:

We approached 45 women for consent, of whom 23 agreed to participate. We included 20 mothers and 38 of their children. Of the 20 included mothers, 5 (25%) had children who were hepatitis B immune by exposure and 3 (15%) had children with evidence of chronic hepatitis B infection at the time of assessment. Hepatitis B immunoglobulin (HBIg) had been given at birth in 29/38 (76.3, 95% CI 59.8-88.6) children, and 26 children (68.4, 95% CI 51.3-82.5) were fully vaccinated. Of the 3 children who had chronic hepatitis B, all had received HBIg at birth and two were fully vaccinated. Of the 5 who were immune by exposure, 4 had received HBIg at birth and one was fully vaccinated. Whole genome sequencing revealed one episode of definite mother to child transmission. There was also one definite case of horizontal transmission.

CONCLUSIONS:

Chronic hepatitis B in this context is a sensitive issue, with a high proportion of women refusing consent. Although uncommon, there is ongoing transmission of hepatitis B to Aboriginal children in remote northern Australia despite vaccination, and this is likely occurring by both vertical and horizontal routes. Prevention will require ongoing investment to overcome the many barriers experienced by this population in accessing care.

• Authors: Richard P Sullivan, Jane Davies, Paula Binks, Melita McKinnon, Roslyn Gundjirryiir Dhurrkay, Kelly Hosking, Sarah Mariyalawuy Bukulatjpi, Stephen Locarnini, Margaret Littlejohn, Kathy Jackson, Steven Y C Tong, Joshua S Davis
• Journal: International journal for equity in health (Int J Equity Health) Vol. 21 Issue 1 Pg. 186 (12 28 2022) ISSN: 1475-9276 [Electronic] England
• PMID: 36575515 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: © 2022. The Author(s).

Chemical References

• Hepatitis B Vaccines

Topics

• Child
• Infant, Newborn
• Child, Preschool
• Female
• Humans
• Hepatitis B, Chronic (prevention & control)
• Hepatitis B Vaccines
• Infectious Disease Transmission, Vertical (prevention & control)
• Hepatitis B (prevention & control)
• Northern Territory (epidemiology)